Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We have downgraded our long-term recommendation on Johnson Controls Inc. ( JCI - Analyst Report ) to Underperform. The leading supplier of automotive interiors, batteries and other control equipment is facing challenges from the softness in the global markets along with weak euro, which will affect its profitability. Pricing pressure from OEMs and strong competition also contributed towards the rating downgrade.
The company is facing continued pricing pressure from OEMs due to their high levels of inventory. In addition, volatility in commodity prices of steel, aluminum, copper and fuel in the Building Efficiency business and lead in the Power Solutions business will impair the company’s profitability.
Johnson Controls faces tough competition from major domestic and international manufacturers and distributors of lead-acid batteries in the North American, European and Asian markets. Its main competitors include Magna International Inc. ( MGA - Analyst Report ) in the Automotive Experience segment, Honeywell International Inc. ( HON - Analyst Report ) in the Building Efficiency segment and Exide Technologies ( XIDE - Snapshot Report ) in the Power Solutions segment. In addition, weak demand in the key markets along with a weak euro can also be detrimental to the company’s profitability.
Meanwhile, Johnson Controls is launching new hybrid batteries along with the expansion of its capacity to meet the rising demand. Concurrently, the company is expanding its foothold with the acquisition of the Delphi global battery business. In addition, the company is the leading supplier of start-stop batteries in Europe. Johnson Controls expects the market for start-stop batteries to grow to 35 million units by 2015.
The company expects to benefit from its expansion in China. In the seating business, it commands more than 50% of the country’s market share. Further, the company has invested $500 million in four automotive battery plants in and around Shanghai which will have an annual production capacity of 30 million batteries by 2015.
Johnson Controls, in the third quarter of its fiscal year ending September 30, 2012, registered a 14% increase in adjusted earnings per share to 64 cents from 56 cents in the corresponding quarter a year ago. However, the results missed the Zacks Consensus Estimate by 3 cents. Profit grew 15% to $441 million from $383 million in the comparable quarter of prior year.
Total revenues rose 2% year over year to $10.6 billion in the quarter. However, revenues failed to meet the Zacks Consensus Estimate of $10.9 billion.
Our recommendation on the stock is backed by a Zacks #4 Rank, which translates into a short-term (1 to 3 months) Sell rating.
Read the full Analyst Report on JCI
Read the full Analyst Report on HON
Read the full Snapshot Report on XIDE
Read the full Analyst Report on MGA